http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014370102-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-683
filingDate 2014-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc42f1929a0c745c0ba325b51ec26331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0312276d7b0be43aafc6f01a186f9a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ca4b63652b5d9cc297051f881ca1582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_727f9e840c7d1eb70e2da7ef9a722259
publicationDate 2014-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014370102-A1
titleOfInvention Method and composition for pharmaceutical product
abstract This invention is directed to a composition comprising dry granulated tenofovir DF and emtricitabine, and a method for making same. Dry granulation was unexpectedly found to be important in preparing a tenofovir DF containing composition suitable for inclusion in a combination dosage form containing emtricitabine, efavirenz and tenofovir DF.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545414-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9744181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9457036-B2
priorityDate 2005-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4384005-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003203969-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453266653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158560827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247102634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453292099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239486323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157326070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239486321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453030527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID224235972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414484810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID325035416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11954236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58850802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239486319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223766454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID348137323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56925685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245469468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454519171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245295741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID464205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447818096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58850801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415826119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223794678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232130491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 86.